Research Center
MBPharma's in-house research division handles development from the active substance through to the finished dosage form. We create medicines, dietary supplements and cosmeceuticals based on compounds of natural and synthetic origin, publish our findings in peer-reviewed journals and protect them with patents.
What the Research Center does
The research division supports a product throughout its entire life cycle — from the initial idea and the creation of an active substance to introduction into medical practice. The client receives not a copycat formulation but a development backed by evidence.
Technological development is carried out at our own innovation facilities: synthesis and isolation of active substances, formulation selection, technology refinement and scale-up to industrial production.
Pilot studies involve leading Russian research institutions — Pirogov Russian National Research Medical University, RUDN University and the Institute of Chemical Diversity Research.
Preclinical and clinical studies are conducted at more than 50 medical institutions across the country.
Results are published as monographs, papers in peer-reviewed journals and conference presentations. The publications are available in the section below — a verifiable body of research underpinning every product we develop.
Patents
Certificate of Compliance of the Manufacturer of Medicinal Products for Medical Use with the Requirements of Good Manufacturing Practice
